Immunome Inc

IMNM's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

IMNM Growth rates comparisons

Immunome Inc 's sales fell in the third quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.16 %

Immunome Inc net loss increased from $-4 millions, to $-57 millions in third quarter of 2025,

• More on IMNM's Growth

IMNM's Valuation comparisons

Immunome Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 8.52 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 173.79.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.

• More on IMNM's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	3.00

IMNM's Valuation comparisons

Immunome Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 8.52 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 173.79.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.

Immunome Inc Price to Book Ratio is at 5.67 lower than Industry Avg. of 105.06. and higher than S&P 500 Avg. of 0.02

• More on IMNM's Valuation

• Market Capitalization (Millions $)	1,496
• Shares Outstanding (Millions)	88
• Employees	35
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-235
• Cash Flow (TTM) (Millions $)	176
• Capital Exp. (TTM) (Millions $)	-19
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	3.00

• Market Capitalization (Millions $)	1,496
• Shares Outstanding (Millions)	88
• Employees	35
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-235
• Cash Flow (TTM) (Millions $)	176
• Capital Exp. (TTM) (Millions $)	-19

	*Ratio*
• Capital Ratio (MRQ)	8.9
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	0.13
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

IMNM's Profitability Comparisons

• More on IMNM's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.